Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Uluru
Uluru
(ULU)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Amlexanox
Amlexanox
2004-09-29
Atopic dermatitis
,
Rhinitis
,
Ulcer
Aphthasol
Amlexanox
1996-12-17
Atopic dermatitis
,
Rhinitis
,
Ulcer
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Salicylic acid
smallpox
,
monkeypox mpox
,
orthopoxvirus
Carboxymethylcellulose
lipodystrophy
,
hiv-associated lipodystrophy syndrome
,
ulcerative colitis
,
colitis
,
ulcer
,
hiv infections
,
infections
,
acquired immunodeficiency syndrome
,
communicable diseases
,
hepatitis b
,
chronic hepatitis b
,
hepatitis
,
chronic hepatitis
,
hepatitis a
Collastat
keratoconus
Articular
osteoarthritis
,
psoriatic arthritis
,
spondylarthritis
,
spondylitis
,
rheumatic diseases
,
non-radiographic axial spondyloarthritis
,
axial spondyloarthritis
,
arthritis
,
rheumatoid arthritis
,
cardiovascular diseases
,
joint diseases
,
ankylosing spondylitis
,
ulcerative colitis
,
uveitis
,
crohn disease
,
anterior uveitis
,
iridocyclitis
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use